| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff3c997f40df01025ddefcb14a6ffa2a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-1205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-083
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0413
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-1003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-091 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-1204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12 |
| filingDate |
2020-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eec1b05ae500bafd6410891b111cb46e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22e6f24f97c9b6400b18a42f8a9ca5a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c19c71cc1292a392104260dd91720dff |
| publicationDate |
2020-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020231842-A1 |
| titleOfInvention |
Embolization with transient materials |
| abstract |
Use of embolic material that is biodegradable provides for embolizing a hypervascular vessel formed in response to chronic inflammation in a musculoskeletal vasculature or a vessel related to production of ghrelin. The embolic material is biodegradable within a predetermined period of time. Medical systems are configured for delivery of embolic material for embolizing the hypervascular vessel or the vessel related to production of ghrelin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022047544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022047545-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022123049-A1 |
| priorityDate |
2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |